[
ZÜRICH, SWITZERLAND, FEBRUARY 3, 2021] Piavita AG has partnered with the Zurich University of Applied Sciences (ZHAW) and the University of Bern with support from the Swiss Federal Fund, Innosuisse, to pursue a research study with the goal of further developing its vital sign monitoring technology the Piavet System to detect the onset of foaling in horses. This study the largest known birth data collection project to date is titled “Piabreed: Machine Learning for Automated Ovulation and Birth Monitoring in Horses.” This year, the Piabreed Project will focus on one of the two sub projects: the industry’s need for better, less invasive, and more cost effective monitoring of foaling mares.
Cross-border distribution of funds to investors in Switzerland continues to be subject to debate and, unfortunately, uncertainty. Even though for the time being, it remains unclear whether every fund offering automatically qualifies as a financial service under Swiss law or not, the latest decision of the Swiss Parliament to introduce alleviations to the strict requirement for financial service providers to be affiliated with an ombudsman (the Ombudsman) shows a tendency into the right direction, which is to avoid unnecessary overregulation.
The aim of this article is to address the following two questions: first, is a cross-border fund offering in any case a financial service in the sense of the new Swiss Financial Services Act (FinSA), and, second, should this be the case, what Swiss law regulatory requirements would such an offering have to comply with.